A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Titel:
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Auteur:
Heerspink, Hiddo J.L. Cherney, David Postmus, Douwe Stefánsson, Bergur V. Chertow, Glenn M. Dwyer, Jamie P. Greene, Tom Kosiborod, Mikhail Langkilde, Anna Maria McMurray, John J.V. Correa-Rotter, Ricardo Rossing, Peter Sjöström, C. David Toto, Robert D. Wheeler, David C.